Release Date: 30/04/10 10:01 Summary: Quarterly Activities Report and Cash Flow Report Price Sensitive: Yes Download Document 933.55KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%